510(K) CLEARANCES 67 ▼8RECALLS POSTED 26CLASS I 2PMA DECISIONS 40 ▼14WEEK ENDING / FDA DATA AS OF
Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2169-2017Class III

AIA-PACK TgAb CONTROL SET

Tosoh Bioscience Inc / initiated 2017-02-08 / Terminated / root cause: labeling and UDI

Tosoh Bioscience, Inc. began a recall of AIA-PACK TgAb CONTROL SET on . FDA classified it as Class III and gives the reason as "The label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (AIA). Two sets of instructions were...". As of , the recall status on record is Terminated, and MDM tags the root cause as labeling and UDI.

Recall record

Recall number
Z-2169-2017
Classification
Class III
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
Tosoh Bioscience Inc
Product
AIA-PACK TgAb CONTROL SET
Product code
JZO System, Test, Thyroid Autoantibody
Reason for recall
The label contains two different methodologies. Quality Control values for non-FDA approved methodology (CL) are on the label in addition to the FDA approved methodology values (AIA). Two sets of instructions were included on the label.
Root cause tag
labeling and UDI
FDA root cause
Labeling mix-ups
Action
On 3/3/2017 the firm sent recall notificaion letters to their customers.
Quantity in commerce
64 boxes
Distribution
Product was shipped to the following states: AK, FL, GA, MA, NY, NY, OH, OK & TX.
Product codes and lots
TgAb: G644899 Expires June 2017; G844801 Expires August 2017 & GX44802 Expires 09/30/2017.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2169-2017
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2168-2017Class IIITerminatedVoluntary: Firm initiated
Z-2169-2017Class IIITerminatedVoluntary: Firm initiated